Al-Hassi, Hafid O.
Ng, Oliver
Evstatiev, Rayko
Mangalika, Manel
Worton, Natalie
Jambrich, Manuela
Khare, Vineeta
Phipps, Oliver
Keeler, Barrie
Gasche, Christoph
Acheson, Austin G.
Brookes, Matthew J.
Funding for this research was provided by:
The Rotha Abraham Bequest, the Royal Wolverhampton NHS Trust, Wolverhampton, UK.
National Institute for Health Research (grant number PB-PG-0110-21041)
The Medical Scientific Fund of the Mayor of the City of Vienna, Vienna, Austria.
Article History
Received: 31 August 2020
Accepted: 10 June 2021
First Online: 1 July 2021
Competing interests
: HOA, ON, MM, NW, MJ, OP, VK and BK declare that they have no conflict of interest. MJB research department has received grant support from Tillotts Pharma and Vifor Pharma (Switzerland). MJB has received honoraria and travel support for consulting or lecturing from Vifor Pharma, Tillotts Pharma and Abbvie. AA research department has received grant support from Pharmacosmos, Denmark and Vifor Pharma, Switzerland. Honoraria or travel support received for lecturing from the following companies: Olympus, Essex, UK., Vifor Pharma Ltd, Switzerland and Pharmacosmos, Denmark. CG: Advisory Board/Consultant/Speaker’s Bureau: Fresenius Medical Care, Pharmacosmos A/S, Renapharma Sweden, Vifor Int.; Grant/Research Support: AOP Orphan Pharmaceuticals, Biogena Naturstoffe GmbH. RE: Advisory Board for AOP Orphan Pharmaceuticals, Speaker’s honoraries from Vifor Pharma Int and AOP Orphan Pharmaceuticals.